Validation of a novel neuroimaging signature for dementia and clinical Alzheimer's disease in the population-based Rotterdam study

BackgroundA novel neuroimaging signature of regional cortical thickness on brain MRI recently showed high potential for Alzheimer's disease and related dementias (ADRD) risk stratification in the community. How these findings translate to other populations, remains undetermined.ObjectiveWe aimed to replicate this novel ADRD neuroimaging marker in the population-based Rotterdam Study.MethodsWe included all participants from the population-based Rotterdam Study with brain-MRI between 2005-2016, and derived the signature using FreeSurfer. We computed hazard ratios and C-statistics for 10-year dementia risk, and betas for cross-sectional associations with cognition, comparing the novel signature to hippocampal volume, mean cortical thickness, and another cortical thickness signature (Dickerson's).ResultsOf 3249 participants (mean age 71.3 ± 8.0 years), 294 developed dementia (74.8% clinical AD) during a mean follow-up of 8.1 years. The novel ADRD signature had similar magnitude of associations as Dickerson's signature and cortical thickness for AD dementia (HR per 1-SD increase 0.87;0.78-0.96), but performed worse than all markers for all-cause dementia. Of the four neuroimaging markers, hippocampal volume showed the strongest associations with both risk of all-cause dementia and clinical AD dementia. The ADRD had the weakest association with general cognitive function (β per 1-SD increase 0.04;0.02-0.06), and executive function (β per 1-SD increase 0.02;0.00-0.04), followed by cortical thickness and Dickerson's, and hippocampal volume showed the strongest associations.ConclusionsIn this community-based study, the novel cortical thickness signature did not outperform hippocampal volume for dementia risk stratification. The importance of replication studies underlines the value of the current study. Replicating research findings is essential to establish robust biomarkers for dementia risk prediction.

Authors

Institutions

Publication Details

Journal
Journal of Alzheimer s Disease
Published
2025-02-16
DOI
https://doi.org/10.1177/13872877251315044
Citations
1
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
1.47

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Validation of a novel neuroimaging signature for dementia and clinical Alzheimer's disease in the population-based Rotterdam study

Meike Willemijn Vernooij, Gennady V. Roshchupkin, M. Arfan Ikram, Frank J. Wolters et al.
1 citations
Journal of Alzheimer s Disease
Dementia and Cognitive Impairment Research
1.47
article

Validation of a novel neuroimaging signature for dementia and clinical Alzheimer's disease in the population-based Rotterdam study

Meike Willemijn Vernooij, Gennady V. Roshchupkin, M. Arfan Ikram, Frank J. Wolters, Jacqueline J. Claus, Mathijs T. Rosbergen
article en
1 citations

Abstract

BackgroundA novel neuroimaging signature of regional cortical thickness on brain MRI recently showed high potential for Alzheimer's disease and related dementias (ADRD) risk stratification in the community. How these findings translate to other populations, remains undetermined.ObjectiveWe aimed to replicate this novel ADRD neuroimaging marker in the population-based Rotterdam Study.MethodsWe included all participants from the population-based Rotterdam Study with brain-MRI between 2005-2016, and derived the signature using FreeSurfer. We computed hazard ratios and C-statistics for 10-year dementia risk, and betas for cross-sectional associations with cognition, comparing the novel signature to hippocampal volume, mean cortical thickness, and another cortical thickness signature (Dickerson's).ResultsOf 3249 participants (mean age 71.3 ± 8.0 years), 294 developed dementia (74.8% clinical AD) during a mean follow-up of 8.1 years. The novel ADRD signature had similar magnitude of associations as Dickerson's signature and cortical thickness for AD dementia (HR per 1-SD increase 0.87;0.78-0.96), but performed worse than all markers for all-cause dementia. Of the four neuroimaging markers, hippocampal volume showed the strongest associations with both risk of all-cause dementia and clinical AD dementia. The ADRD had the weakest association with general cognitive function (β per 1-SD increase 0.04;0.02-0.06), and executive function (β per 1-SD increase 0.02;0.00-0.04), followed by cortical thickness and Dickerson's, and hippocampal volume showed the strongest associations.ConclusionsIn this community-based study, the novel cortical thickness signature did not outperform hippocampal volume for dementia risk stratification. The importance of replication studies underlines the value of the current study. Replicating research findings is essential to establish robust biomarkers for dementia risk prediction.

Journal of Alzheimer s DiseaseVol. 108(1_suppl)
Erasmus MC (NL)
Alzheimer's Association, ZonMw, Hartstichting
Good health and well-being
Openalex Percentile: Top 22%
Dementia and Cognitive Impairment Research
1.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.